Stockscreener 앱 받기
57.43
0.45%
0.1367
전일 마감가:
$57.30
열려 있는:
$57.22
하루 거래량:
360.92K
Relative Volume:
0.10
시가총액:
$25.46B
수익:
$2.44B
순이익/손실:
$1.36B
주가수익비율:
30.08
EPS:
1.9093
순현금흐름:
$574.14M
1주 성능:
+3.38%
1개월 성능:
+8.67%
6개월 성능:
+44.89%
1년 성능:
+61.43%
1일 변동 폭
$56.90
$57.78
1주일 범위
$54.95
$59.44
52주 변동 폭
$34.08
$59.44
로열티 파마 Stock (RPRX) Company Profile
명칭
Royalty Pharma Plc
전화
(212) 883-0200
주소
110 EAST 59TH STREET, NEW YORK, NY
Compare RPRX vs VRTX, REGN, ARGX, RVMD, ALNY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
57.43 | 25.40B | 2.44B | 1.36B | 574.14M | 1.9093 |
VRTX
Vertex Pharmaceuticals Inc
|
481.91 | 121.95B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
674.72 | 70.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
873.90 | 52.94B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
182.20 | 38.35B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
274.89 | 36.40B | 4.29B | 577.22M | 641.34M | 4.2086 |
로열티 파마 Stock (RPRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-30 | 업그레이드 | UBS | Neutral → Buy |
| 2025-09-30 | 개시 | Goldman | Buy |
| 2025-05-16 | 개시 | Morgan Stanley | Overweight |
| 2024-06-03 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-06-14 | 재개 | UBS | Buy |
| 2022-05-13 | 개시 | Scotiabank | Sector Outperform |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2022-04-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-04-06 | 재개 | Morgan Stanley | Overweight |
| 2021-10-29 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-07-30 | 개시 | Tigress Financial | Buy |
| 2020-11-09 | 업그레이드 | UBS | Neutral → Buy |
| 2020-07-14 | 개시 | Evercore ISI | In-line |
| 2020-07-13 | 개시 | BofA Securities | Buy |
| 2020-07-13 | 개시 | Citigroup | Neutral |
| 2020-07-13 | 개시 | Cowen | Outperform |
| 2020-07-13 | 개시 | Goldman | Neutral |
| 2020-07-13 | 개시 | JP Morgan | Neutral |
| 2020-07-13 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-07-13 | 개시 | SunTrust | Buy |
| 2020-07-13 | 개시 | UBS | Neutral |
모두보기
로열티 파마 주식(RPRX)의 최신 뉴스
SEB Asset Management AB Invests $12.97 Million in Royalty Pharma PLC $RPRX - MarketBeat
California Public Employees Retirement System Cuts Stake in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX Holdings Lowered by AlTi Global Inc. - MarketBeat
How (RPRX) Movements Inform Risk Allocation Models - Stock Traders Daily
Hsbc Holdings PLC Acquires 1,486,020 Shares of Royalty Pharma PLC $RPRX - MarketBeat
RPHC5824521 Bond Profile — Key Metrics - TradingView
Royalty Pharma declares $0.235 dividend - MSN
US78081BAP8 Bond Coupon Profile — Rate & Payments - TradingView
RPHC5237916 Bond Coupon Profile — Rate & Payments - TradingView
RPHC5237916 Bond Profile — Key Metrics - TradingView
RPHC6166012 Bond Risk Profile - TradingView
Royalty Pharma declares $0.235 quarterly dividend By Investing.com - Investing.com South Africa
Royalty Pharma declares $0.235 quarterly dividend - Investing.com UK
Press Release: Royalty Pharma Declares Third Quarter 2026 Dividend - Moomoo
Royalty Pharma Maintains Quarterly Dividend at $0.235 a Share, Payable on Sept. 10 to Shareholders of Record on Aug. 14 - marketscreener.com
Royalty Pharma Announces Third Quarter 2026 Dividend of $0.235 per Class A Ordinary Share - Quiver Quantitative
Royalty Pharma plc (RPRX) Declares $0.235 Quarterly Dividend; 1.6% Yield - StreetInsider
Royalty Pharma declares third quarter 2026 dividend - Yahoo Finance Singapore
Royalty Pharma stock hits all-time high at 58.85 USD By Investing.com - Investing.com South Africa
RPHC6166012 Bond Coupon Profile — Rate & Payments - TradingView
Royalty Pharma (NASDAQ:RPRX) Sets New 12-Month HighHere's Why - MarketBeat
Royalty Pharma PLC $RPRX Shares Sold by C WorldWide Group Holding A S - MarketBeat
Royalty Pharma stock hits all-time high at 58.85 USD - Investing.com UK
RPHC5824522 Bond Coupon Profile — Rate & Payments - TradingView
Royalty Pharma to announce Q2 2026 financial results on August 5 - scanx.trade
Royalty Pharma schedules 8 a.m. webcast for Aug. 5 results - Stock Titan
RPHC5222527 Bond Profile — Key Metrics - TradingView
Royalty Pharma to announce second quarter 2026 financial results on August 5, 2026 - Yahoo Finance
US78081BAN3 Bond Coupon Profile — Rate & Payments - TradingView
US78081BAN3 Bond Risk Profile - TradingView
Royalty Pharma PLC $RPRX Shares Sold by J. Safra Sarasin Holding AG - MarketBeat
Calamos Advisors LLC Takes Position in Royalty Pharma PLC $RPRX - MarketBeat
RPHC5824522 Bond Risk Profile - TradingView
US78081BAN3 Bond Profile — Key Metrics - TradingView
RPHC5824522 Bond Profile — Key Metrics - TradingView
Calamos Wealth Management LLC Acquires New Shares in Royalty Pharma PLC $RPRX - MarketBeat
US78081BAQ6 Bond Coupon Profile — Rate & Payments - TradingView
Canal Insurance CO Acquires Shares of 20,000 Royalty Pharma PLC $RPRX - MarketBeat
RPHC5237891 Bond Profile — Key Metrics - TradingView
Royalty Pharma (RPRX) Bernstein Insights: Healthcare Leaders and Disruptors2nd Annual Healthcare Forum summary - Quartr
RPHC5237891 Bond Coupon Profile — Rate & Payments - TradingView
RPHC5237891 Bond Risk Profile - TradingView
US78081BAQ6 Bond Risk Profile - TradingView
US78081BAQ6 Bond Profile — Key Metrics - TradingView
Royalty Pharma (RPRX) Stock Analysis: A Strategic Look At Growth And Valuation Potential - DirectorsTalk Interviews
Royalty Pharma Q1 2026 earnings preview - MSN
World Investment Advisors Sells 48,485 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX is Torray Investment Partners LLC's Largest Position - MarketBeat
Hsbc Holdings PLC Lowers Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (RPRX) Morgan Stanley’s 22nd Annual Global Healthcare Conference summary - Quartr
Royalty Pharma (RPRX) Citi Annual Global Healthcare Conference 2025 Summary - Quartr
로열티 파마 (RPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.03%
자본화:
|
볼륨(24시간):